2017 Q1 Form 10-Q Financial Statement

#000119312517244242 Filed on August 01, 2017

View on sec.gov

Income Statement

Concept 2017 Q1 2016 Q3
Revenue $14.92M
YoY Change -27.08%
Cost Of Revenue $8.791M
YoY Change -30.52%
Gross Profit $6.127M
YoY Change -21.51%
Gross Profit Margin 41.07%
Selling, General & Admin $4.957M
YoY Change 8.33%
% of Gross Profit 80.9%
Research & Development $4.977M
YoY Change 68.88%
% of Gross Profit 81.23%
Depreciation & Amortization $1.480M
YoY Change 28.7%
% of Gross Profit 24.16%
Operating Expenses $9.934M
YoY Change 32.05%
Operating Profit -$3.807M
YoY Change -1445.23%
Interest Expense $87.00K
YoY Change -769.23%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$3.720M
YoY Change -1477.78%
Income Tax -$230.0K
% Of Pretax Income
Net Earnings -$3.490M
YoY Change -29183.33%
Net Earnings / Revenue -23.39%
Basic Earnings Per Share -$0.17
Diluted Earnings Per Share -$0.17
COMMON SHARES
Basic Shares Outstanding 21.39M shares 20.69M shares
Diluted Shares Outstanding 20.69M shares

Balance Sheet

Concept 2017 Q1 2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $35.40M
YoY Change -25.94%
Cash & Equivalents $27.04M $18.73M
Short-Term Investments $16.70M
Other Short-Term Assets $1.147M
YoY Change 23.47%
Inventory $22.49M
Prepaid Expenses
Receivables $16.80M
Other Receivables $0.00
Total Short-Term Assets $76.30M
YoY Change -3.86%
LONG-TERM ASSETS
Property, Plant & Equipment $11.73M
YoY Change -5.12%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $5.200M
YoY Change -44.09%
Other Assets $919.0K
YoY Change -58.23%
Total Long-Term Assets $22.36M
YoY Change -18.29%
TOTAL ASSETS
Total Short-Term Assets $76.30M
Total Long-Term Assets $22.36M
Total Assets $98.67M
YoY Change -7.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.040M
YoY Change -3.09%
Accrued Expenses $3.617M
YoY Change -42.12%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $26.96M
YoY Change 80.63%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $2.883M
YoY Change 11.48%
Total Long-Term Liabilities $2.883M
YoY Change 11.48%
TOTAL LIABILITIES
Total Short-Term Liabilities $26.96M
Total Long-Term Liabilities $2.883M
Total Liabilities $29.84M
YoY Change 70.42%
SHAREHOLDERS EQUITY
Retained Earnings -$72.26M
YoY Change 28.62%
Common Stock $169.1M
YoY Change 3.06%
Preferred Stock
YoY Change
Treasury Stock (at cost) $28.49M
YoY Change 47.86%
Treasury Stock Shares 4.845M shares
Shareholders Equity $73.27M $68.83M
YoY Change
Total Liabilities & Shareholders Equity $98.67M
YoY Change -7.56%

Cashflow Statement

Concept 2017 Q1 2016 Q3
OPERATING ACTIVITIES
Net Income -$3.490M
YoY Change -29183.33%
Depreciation, Depletion And Amortization $1.480M
YoY Change 28.7%
Cash From Operating Activities -$1.860M
YoY Change -180.17%
INVESTING ACTIVITIES
Capital Expenditures -$790.0K
YoY Change 29.51%
Acquisitions
YoY Change
Other Investing Activities -$210.0K
YoY Change -105.85%
Cash From Investing Activities -$990.0K
YoY Change -133.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -180.0K
YoY Change -97.05%
NET CHANGE
Cash From Operating Activities -1.860M
Cash From Investing Activities -990.0K
Cash From Financing Activities -180.0K
Net Change In Cash -3.030M
YoY Change 269.51%
FREE CASH FLOW
Cash From Operating Activities -$1.860M
Capital Expenditures -$790.0K
Free Cash Flow -$1.070M
YoY Change -136.52%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
30000000
CY2017Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
21782377 shares
CY2016Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
776000
CY2016Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
906000
CY2017Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
1106000
CY2017Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
837000
CY2016Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
592000
CY2016Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
748000
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18733000
CY2017Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
4845000 shares
CY2017Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2109908 shares
CY2017Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
174245000
CY2017Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
1500000
CY2017Q3 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
1014000
CY2017Q3 us-gaap Standard Product Warranty Accrual Noncurrent
StandardProductWarrantyAccrualNoncurrent
206000
CY2017Q3 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
1400000
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.22
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2982631 shares
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.63
CY2017Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-68070000
CY2017Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3335000
CY2017Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
113203000
CY2017Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6010000
CY2017Q3 us-gaap Business Combination Liabilities Arising From Contingencies Amount Recognized
BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized
859000
CY2017Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
399000
CY2017Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
9529000
CY2017Q3 us-gaap Stockholders Equity
StockholdersEquity
78107000
CY2017Q3 us-gaap Common Stock Value
CommonStockValue
22000
CY2017Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6556000
CY2017Q3 us-gaap Customer Advances Current
CustomerAdvancesCurrent
13178000
CY2017Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2017Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
1220000
CY2017Q3 us-gaap Liabilities Current
LiabilitiesCurrent
31761000
CY2017Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
859000
CY2017Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3044000
CY2017Q3 us-gaap Assets Current
AssetsCurrent
89417000
CY2017Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
15096000
CY2017Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0
CY2017Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
19000
CY2017Q3 us-gaap Deferred Income Taxes And Other Assets Noncurrent
DeferredIncomeTaxesAndOtherAssetsNoncurrent
743000
CY2017Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
9880000
CY2017Q3 us-gaap Other Assets Current
OtherAssetsCurrent
1230000
CY2017Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12244000
CY2017Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1400000
CY2017Q3 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
29649000
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19575000
CY2017Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
4000
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
328000
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
273000
CY2017Q3 us-gaap Inventory Net
InventoryNet
26834000
CY2017Q3 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
7568000
CY2017Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
41360000
CY2017Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
19000
CY2017Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
14217000
CY2017Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
26635000
CY2017Q3 us-gaap Assets
Assets
113203000
CY2017Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
0
CY2017Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
41379000
CY2017Q3 us-gaap Available For Sale Securities
AvailableForSaleSecurities
29630000
CY2017Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
22068000
CY2017Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
716000
CY2017Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
22062000
CY2017Q3 us-gaap Debt Instrument Collateral Amount
DebtInstrumentCollateralAmount
1400000
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
615000
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
615000
CY2017Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1831000
CY2017Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
8387000
CY2017Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
605000
CY2017Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
16349000
CY2017Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2156000
CY2017Q3 us-gaap Treasury Stock Value
TreasuryStockValue
28489000
CY2017Q3 ivac Common Property Plant And Equipment
CommonPropertyPlantAndEquipment
1682000
CY2017Q3 ivac Availableforsale Securities Debt Maturities After One Through Two Years Amortized Cost
AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsAmortizedCost
7581000
CY2017Q3 ivac Available For Sale Securities Debt Maturities After One Through Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue
7568000
CY2016Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
982000
CY2016Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
890000
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13746000
CY2016Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
4845000 shares
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-69901000
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3082000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
108324000
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4220000
CY2016Q4 us-gaap Business Combination Liabilities Arising From Contingencies Amount Recognized
BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized
759000
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
321000
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5323000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
73266000
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
21000
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
171314000
CY2016Q4 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
829000
CY2016Q4 us-gaap Standard Product Warranty Accrual Noncurrent
StandardProductWarrantyAccrualNoncurrent
178000
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6129000
CY2016Q4 us-gaap Customer Advances Current
CustomerAdvancesCurrent
5422000
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1000
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2016Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
1007000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
31976000
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
17011000
CY2016Q4 us-gaap Assets Current
AssetsCurrent
88736000
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
23000
CY2016Q4 us-gaap Deferred Income Taxes And Other Assets Noncurrent
DeferredIncomeTaxesAndOtherAssetsNoncurrent
898000
CY2016Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
6470000
CY2016Q4 us-gaap Other Assets Current
OtherAssetsCurrent
997000
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11237000
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1602000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27043000
CY2016Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
3000
CY2016Q4 us-gaap Inventory Net
InventoryNet
24876000
CY2016Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
3593000
CY2016Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
48238000
CY2016Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
871000
CY2016Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
17602000
CY2016Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
17447000
CY2016Q4 us-gaap Assets
Assets
108324000
CY2016Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
48260000
CY2016Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2258000
CY2016Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
8116000
CY2016Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
10290000
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1768000
CY2016Q4 us-gaap Treasury Stock Value
TreasuryStockValue
28489000
CY2016Q4 ivac Common Property Plant And Equipment
CommonPropertyPlantAndEquipment
1039000
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2740364 shares
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.00
CY2017Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
1007000
CY2017Q1 us-gaap New Accounting Pronouncement Or Change In Accounting Principle Cumulative Effect Of Change On Equity Or Net Assets1
NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssets1
1100000
CY2017Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
759000
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27043000
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>2. Recent Accounting Pronouncements</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> In May 2017, the Financial Accounting Standards Board (&#x201C;FASB&#x201D;) issued Accounting Standards Update (&#x201C;ASU&#x201D;) 2017-09, <i>Compensation - Stock Compensation: Scope of Modification Accounting</i>, which provides guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting. An entity will account for the effects of a modification unless the fair value of the modified award is the same as the original award, the vesting conditions of the modified award are the same as the original award and the classification of the modified award as an equity instrument or liability instrument is the same as the original award. This update becomes effective and will be adopted by Intevac in the first quarter of fiscal&#xA0;2019. The update is to be adopted prospectively to an award modified on or after the adoption date. Early adoption is permitted. Intevac does not expect the adoption of this update to have a material impact on its consolidated financial statements.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> In March 2017, the FASB issued ASU 2017-08, <i>Receivables &#x2013; Nonrefundable Fees and Other Costs (Subtopic 310-20): Premium Amortization on Purchased Callable Debt Securities</i>. ASU 2017-08 amends the amortization period for certain purchased callable debt securities held at a premium, shortening such period to the earliest call date. This update becomes effective and will be adopted by Intevac in the first quarter of fiscal&#xA0;2019. Intevac does not expect the adoption of this update to have a material impact on its consolidated financial statements.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> In January 2017, the FASB issued ASU 2017-04, <i>Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment</i>. ASU 2017-04 eliminates Step 2 from the goodwill impairment test. Under Step 2, an entity had to perform procedures to determine the fair value at the impairment testing date of its assets and liabilities (including unrecognized assets and liabilities) following the procedure that would be required in determining the fair value of assets acquired and liabilities assumed in a business combination. Instead, under the amendments in ASU 2017-04, an entity should perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An entity should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit&#x2019;s fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. Additionally, an entity should consider income tax effects from any tax deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss, if applicable. An entity still has the option to perform the qualitative assessment for a reporting unit to determine if the quantitative impairment test is necessary. This update becomes effective and will be adopted by Intevac in the first quarter of fiscal&#xA0;2020. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January&#xA0;1,&#xA0;2017. Intevac does not expect the adoption of this update to have a material impact on its consolidated financial statements.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"> &#xA0;</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt; TEXT-INDENT: 4%"> In March 2016, the FASB issued ASU 2016-09 <i>Compensation&#x2014;Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting</i>. We have adopted these amendments beginning in the first quarter of 2017. Starting in the first quarter of fiscal 2017, stock-based compensation excess tax benefits or deficiencies are reflected in the Condensed Consolidated Statements of Operations as a component of the provision for income taxes, whereas they previously were recognized in equity. Additionally, our Condensed Consolidated Statements of Cash Flows now presents excess tax benefits as an operating activity. Finally, we have elected to account for forfeitures as they occur, rather than estimate expected forfeitures. The net cumulative effect of this change was recognized as a $1.1&#xA0;million charge to the accumulated deficit as of January&#xA0;1,&#xA0;2017. In the first half of 2017, stock-based compensation excess tax benefits of $74,000 were reflected in the Condensed Consolidated Statements of Operations as a component of the provision for income taxes.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> In May 2014, the FASB issued ASU 2014-09 <i>(Topic 606) Revenue from Contracts with Customers.</i> Topic 606 supersedes the revenue recognition requirements in Accounting Standards Codification Topic 605, &#x201C;Revenue Recognition&#x201D;, and requires entities to recognize revenue when they transfer control of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. We expect revenue recognition for our equipment sales arrangements, which includes systems, technology upgrades, service and spare parts, to remain materially consistent with our historical practice.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> We expect to recognize revenue for equipment sales at a point in time following the transfer of control of such products to the customer, which typically occurs upon shipment or delivery depending on the terms of the underlying contracts. Our contracts with customers may include multiple performance obligations. For such arrangements, we expect to allocate revenue to each performance obligation based on its relative standalone selling price. We generally determine standalone selling prices based on the prices charged to customers or using expected cost plus margin. The expected costs associated with our base warranties will continue to be recognized as expense when the equipment is sold.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> We expect to recognize revenue for cost plus fixed fee and firm fixed priced government contracts over time under the cost-to-cost method for the majority of our government contracts, which is consistent with our current revenue recognition model. Revenue on the majority of our government contracts will continue to be recognized over time because of the continuous transfer of control to the customer. For U.S. government contracts, this continuous transfer of control to the customer is supported by clauses in the contract that allow the customer to unilaterally terminate the contract for convenience, pay us for costs incurred plus a reasonable profit and take control of any work in process. Similarly, for non-U.S. government contracts, the customer typically controls the work in process as evidenced either by contractual termination clauses or by our rights to payment for work performed to date to deliver products or services that do not have an alternative use to the company. Under the new standard, the cost-to-cost measure of progress continues to best depict the transfer of control of assets to the customer, which occurs as we incur costs.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> The new standard must be adopted by Intevac in our fiscal year beginning December&#xA0;31, 2017. We intend to adopt the new standard as of December&#xA0;31, 2017, using the modified retrospective transition method applied to those contracts which were not completed as of that date. Upon adoption, we will recognize the cumulative effect of adopting this guidance as an adjustment to our opening balance of the accumulated deficit. Prior periods will not be retrospectively adjusted. Based on our preliminary assessment, we expect the adoption of Topic 606 will not have a material impact to our consolidated financial statements, including the presentation of revenues in our Consolidated Statements of Operations. We also do not expect the standard to have a material impact on our Consolidated Balance Sheet. The immaterial impact primarily relates to reclassifications among financial statement accounts to align with the new standard. Most notably, contracts in process, net will be reclassified as receivables or contract assets based on amounts billed or unbilled, respectively. Advance payments and billings in excess of costs incurred and deferred revenue will be combined and reclassified as contract liabilities. Our contract balances will be reported in a net contract asset or liability position on a contract-by-contract basis at the end of each reporting period.</p> </div>
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
dei Document Type
DocumentType
10-Q
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
75000
dei Entity Central Index Key
EntityCentralIndexKey
0001001902
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-4016000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.03
dei Trading Symbol
TradingSymbol
IVAC
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22999000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21356000 shares
dei Amendment Flag
AmendmentFlag
false
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent
SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
0.85 pure
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
11.82
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
12.42
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
39604 shares
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1643000 shares
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
dei Document Period End Date
DocumentPeriodEndDate
2017-07-01
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
383825 shares
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
195184 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
101954 shares
us-gaap Average Remaining Maturity Of Foreign Currency Derivatives1
AverageRemainingMaturityOfForeignCurrencyDerivatives1
P30D
dei Entity Registrant Name
EntityRegistrantName
INTEVAC INC
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 Segment
us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
-13000
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
506000
us-gaap Sales Revenue Net
SalesRevenueNet
61351000
us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
78000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
237000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
74000
us-gaap Contracts Revenue
ContractsRevenue
3065000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-54000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
58286000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
15608000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
2553000
us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
78000
us-gaap Operating Income Loss
OperatingIncomeLoss
3430000
us-gaap Net Income Loss
NetIncomeLoss
2929000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3007000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1985000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
3000
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
10937000
us-gaap Gross Profit
GrossProfit
24517000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
102000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
78000
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-202000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3667000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
102000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1973000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
75000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
738000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-2992000
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
0
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1452000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
14967000
us-gaap Share Based Compensation
ShareBasedCompensation
1864000
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-6945000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11987000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
36834000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-535000
us-gaap Product Warranty Expense
ProductWarrantyExpense
280000
us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
0
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9100000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
427000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-7468000
us-gaap Contract Revenue Cost
ContractRevenueCost
2816000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
34018000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
2000
us-gaap Operating Expenses
OperatingExpenses
21087000
ivac Purchase Intervals Of Series
PurchaseIntervalsOfSeries
P6M
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
401000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
57000
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-911000
us-gaap Gross Profit
GrossProfit
9982000
ivac Share Based Compensation Arrangement By Share Based Payment Award Conversion Ratio
ShareBasedCompensationArrangementByShareBasedPaymentAwardConversionRatio
1.00 pure
ivac Minimum Product Warranty Range
MinimumProductWarrantyRange
P12M
ivac Payment Of Acquisition Related Contingent Consideration
PaymentOfAcquisitionRelatedContingentConsideration
2000
ivac Maximum Product Warranty Range
MaximumProductWarrantyRange
P24M
ivac Maximum Employee Salary Withholdings For Purchase Of Common Stock Under Terms Of Espp
MaximumEmployeeSalaryWithholdingsForPurchaseOfCommonStockUnderTermsOfEspp
0.15 pure
ivac Share Based Compensation Arrangement By Share Based Payment Award Options Offering Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOfferingPeriod
P2Y
ivac Allocation Of Corporate Expenses To Segments
AllocationOfCorporateExpensesToSegments
0.03 pure
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.48
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-4305000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20621000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20621000 shares
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.48
us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
-261000
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
174000
us-gaap Sales Revenue Net
SalesRevenueNet
28582000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
22000
us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
79000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
125000
us-gaap Contracts Revenue
ContractsRevenue
2218000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-63000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
26364000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
7736000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
2039000
us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
79000
us-gaap Operating Income Loss
OperatingIncomeLoss
-10124000
us-gaap Net Income Loss
NetIncomeLoss
-9795000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9716000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-142000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
79000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9999000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-142000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
9000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2658000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
23000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-204000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
8955000
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
0
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
715000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
18730000
us-gaap Share Based Compensation
ShareBasedCompensation
1991000
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
5490000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
9952000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
18600000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
314000
us-gaap Product Warranty Expense
ProductWarrantyExpense
303000
us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
0
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10154000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
4987000
us-gaap Contract Revenue Cost
ContractRevenueCost
2135000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
16465000
us-gaap Operating Expenses
OperatingExpenses
20106000
CY2016Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
CY2016Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20691000 shares
CY2016Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20691000 shares
CY2016Q3 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
CY2016Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2016Q3 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
-139000
CY2016Q3 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
61000
CY2016Q3 us-gaap Sales Revenue Net
SalesRevenueNet
14918000
CY2016Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
-45000
CY2016Q3 us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
-32000
CY2016Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
87000
CY2016Q3 us-gaap Contracts Revenue
ContractsRevenue
1835000
CY2016Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
13083000
CY2016Q3 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
-32000
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3807000
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-3490000
CY2016Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3522000
CY2016Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
13000
CY2016Q3 us-gaap Gross Profit
GrossProfit
6127000
CY2016Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-158000
CY2016Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-32000
CY2016Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3720000
CY2016Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-230000
CY2016Q3 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
0
CY2016Q3 us-gaap Share Based Compensation
ShareBasedCompensation
880000
CY2016Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4957000
CY2016Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8791000
CY2016Q3 us-gaap Product Warranty Expense
ProductWarrantyExpense
106000
CY2016Q3 us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
0
CY2016Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4977000
CY2016Q3 us-gaap Contract Revenue Cost
ContractRevenueCost
1277000
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1339000
CY2016Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
7514000
CY2016Q3 us-gaap Operating Expenses
OperatingExpenses
9934000
CY2017Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2017Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23209000 shares
CY2017Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21495000 shares
CY2017Q3 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
CY2017Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1714000 shares
CY2017Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2017Q3 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
-4000
CY2017Q3 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
256000
CY2017Q3 us-gaap Sales Revenue Net
SalesRevenueNet
30963000
CY2017Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
41000
CY2017Q3 us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
40000
CY2017Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
127000
CY2017Q3 us-gaap Contracts Revenue
ContractsRevenue
1100000
CY2017Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
29863000
CY2017Q3 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
40000
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
1100000
CY2017Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1140000
CY2017Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-1000
CY2017Q3 us-gaap Gross Profit
GrossProfit
11470000
CY2017Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
22000
CY2017Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
40000
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1466000
CY2017Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
366000
CY2017Q3 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
0
CY2017Q3 us-gaap Share Based Compensation
ShareBasedCompensation
787000
CY2017Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5713000
CY2017Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
19493000
CY2017Q3 us-gaap Product Warranty Expense
ProductWarrantyExpense
138000
CY2017Q3 us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
0
CY2017Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4418000
CY2017Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
213000
CY2017Q3 us-gaap Contract Revenue Cost
ContractRevenueCost
1148000
CY2017Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
18345000
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
10131000

Files In Submission

Name View Source Status
0001193125-17-244242-index-headers.html Edgar Link pending
0001193125-17-244242-index.html Edgar Link pending
0001193125-17-244242.txt Edgar Link pending
0001193125-17-244242-xbrl.zip Edgar Link pending
d422905d10q.htm Edgar Link pending
d422905dex311.htm Edgar Link pending
d422905dex312.htm Edgar Link pending
d422905dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
ivac-20170701.xml Edgar Link completed
ivac-20170701.xsd Edgar Link pending
ivac-20170701_cal.xml Edgar Link unprocessable
ivac-20170701_def.xml Edgar Link unprocessable
ivac-20170701_lab.xml Edgar Link unprocessable
ivac-20170701_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending